CRISPR-edited immune cells can be safely given to cancer patients
The emergence of CRISPR-Cas9 gene-editing technology has spurred hope in both doctors and patients since it shows promise in treating a multitude of diseases, including cancer. For the first time in the United States, a team of scientists has shown that CRISPR-edited immune cells can be safely used to cancer patients.
.jpeg)
No hay comentarios:
Publicar un comentario